modified cholera toxin (ERAD Therapeutics)

N/A

Report date: 2025/03/20 16:02:37

Base Information

Drug Namemodified cholera toxin (ERAD Therapeutics)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > ToxinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGlucosylceramidase stimulants
TargetsGlucosylceramidase
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Hospital For Sick Children
China Registration ClassN/A

Develop Information

Active CompaniesERAD Therapeutics IncThe Hospital For Sick Children
Inactive CompaniesN/A
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A